Following the successful EFI 2024 event in Geneva from 20-23 May, JETA Molecular has attended the American Transplant Congress in Philadelphia (June 1-5). We look forward to welcoming you at our booth during the SFHI Congress in Strasbourg from 9-11 October.

Should you require further information about our products for transplant monitoring, or if you would like to discuss our sensitive detection techniques and simple workflows with our experts, please do not hesitate to contact us!

Our software, developed for the chimerism monitoring after hematopoietic stem-cell transplantation, is now also supporting the new QX600 Droplet Digital PCR System. This new instrument from Biorad enables accurate quantification in combination with advanced six-color (FAM, HEX, Cy5, Cy5.5, ROX, and ATTO 590) multiplexing.

This year, JETA Molecular has for the first time set up a booth at the BSHI Conference 2023 held in Birmingham, UK on September 12-13. We will also be attending the SFHI 2023 meeting (October 11-13 in Reims, France - represented by our business partner Bionobis) and the ASHI 49th Annual Meeting on October 16-20 in San Antonio, Texas.

Please feel welcome to visit our booth and have a chat with us - not only about our increasingly popular DigitalTRACE™ kits!

We are proud to announce that we have recently developed the Extended Panel Genotyping Plate for QIAcuity, allowing our customers to use additional 27 markers in their 4-color digital PCR genotyping analysis. The new plate brings the total number of markers available in the 4-colour genotyping to 70, making DigitalTRACE by far the broadest panel of INDEL markers for multicolor dPCR chimerism analysis currently available on the market.

We invite you to explore the colorful world of digital PCR and join the upcoming Digital PCR Festival 2.0. JETA Molecular´s CEO, Doug Bost, will be addressing the benefits of this ultrasensitive detection method for post-transplant patient monitoring in his presentation called “Applications of Digital PCR for Monitoring Transplant Success – Stem Cell Chimerism Analysis” during the Translational Research session.